Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LINE Lineage

休市中 12-20 16:00:00 EST

58.57

+1.67

+2.93%

盘后58.57

+0.000.00%

19:57 EST

最高58.76	最低56.76	成交量259.73万
今开57.00	昨收56.90	日振幅3.51%
总市值133.65亿	流通市值34.56亿	总股本2.28亿
成交额1.51亿	换手率4.40%	流通股本5,901万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LINE","market":"US","secType":"STK","nameCN":"Lineage","latestPrice":58.57,"timestamp":1734728400000,"preClose":56.9,"halted":0,"volume":2597279,"hourTrading":{"tag":"盘后","latestPrice":58.57,"preClose":58.57,"latestTime":"19:57 EST","volume":368479,"amount":21581816.041,"timestamp":1734742640813},"delay":0,"floatShares":59006054,"shares":228189909,"eps":-4.023617,"marketStatus":"休市中","marketStatusCode":7,"change":1.67,"latestTime":"12-20 16:00:00 EST","open":57,"high":58.76,"low":56.7601,"amount":151309661.924768,"amplitude":0.035148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.023617,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":1721880000000,"adjPreClose":56.9,"dividendRate":0.015878,"preHourTrading":{"tag":"盘前","latestPrice":57.4,"preClose":56.9,"latestTime":"09:29 EST","volume":2286,"amount":130985.7426,"timestamp":1734704975043},"postHourTrading":{"tag":"盘后","latestPrice":58.57,"preClose":58.57,"latestTime":"19:57 EST","volume":368479,"amount":21581816.041,"timestamp":1734742640813},"volumeRatio":2.0207136296606127,"impliedVol":0.24,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/LINE","defaultTab":"news","newsList":[{"id":"2492440999","title":"Lineage Cell Therapeutics, Inc.盘中异动 大幅拉升5.56%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492440999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492440999?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:28","pubTimestamp":1734708521,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日23时28分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速上涨5.56%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220232841984cfd8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220232841984cfd8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","LCTX","BK4224","LENZ"],"gpt_icon":0},{"id":"2492187275","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492187275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492187275?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:36","pubTimestamp":1734532584,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日22时36分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅拉升5.11%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Cognition Therapeutics, Inc.、Tc Biopharm  Plc、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为318.86%、251.56%、92.15%，振幅较大的相关个股有Nkgen Biotech Inc C/Wts 31/05/2028、Cognition Therapeutics, Inc.、Tc Biopharm  Plc，振幅分别为66.83%、48.36%、30.87%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822362495ea54c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121822362495ea54c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4224","LCTX","LINE","BK4139"],"gpt_icon":0},{"id":"2491696806","title":"纳斯达克2024年IPO数量连续第六年超越纽交所，明年前景更加乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=2491696806","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491696806?lang=zh_cn&edition=full","pubTime":"2024-12-16 21:30","pubTimestamp":1734355802,"startTime":"0","endTime":"0","summary":"纳斯达克2024年IPO数量连续第六年超越纽交所，明年前景更加乐观路透纽约12月16日 - 2024年，交易所运营商纳斯达克NDAQ.O有望连续第六年在上市交易数量上超越纽约证券交易所。市场观察人士认为这是 IPO 数量的又一乐观信号。近年来，美联储在 2022 年加息以遏制通胀飙升后，IPO 数量大幅下降。用于预测未来六个月美国 IPO 活动的纳斯达克IPO脉搏指数10月份创下三年多来的新高，预示 2025 年初 IPO 活动将呈现上升趋势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL6S3NH038:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","2NVD.UK","02020","LU1935042215.USD","IE00B3S45H60.SGD","LU1989772840.SGD","NVDD","NVDU","LU1989763005.USD","LU1564329628.SGD","LU2039709279.SGD","RBRK","LU1551013342.USD","NDAQ","NVD2.UK","LU2764263203.CNY","NVDX","NVDS","NVD","ICE","NVDS.UK","LU0960925559.SGD","LU0157215616.USD","3NVD.UK","AS","LINE","LU0316494557.USD","LU2087621335.USD","LU2244417387.USD","LU1852331112.SGD","NVD3.UK","LU1496350502.SGD","NVDY","LU1280957306.USD","SNVD.UK","ANPDY","IE000KEQY171.SGD","VIK","BK1168","NVIW.SI","LU2264538146.SGD","LU1732799900.SGD","IE000YTNTUN2.SGD","82020","LU0650527681.SGD"],"gpt_icon":1},{"id":"2491666404","title":"纳斯达克上市量连续六年居纽约证交所首位，IPO 乐观情绪高涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2491666404","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491666404?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:00","pubTimestamp":1734346815,"startTime":"0","endTime":"0","summary":"路透纽约12月16日 - 随着华尔街期待2025年首次公开募股的丰收，交易所运营商纳斯达克NDAQ.O有望在2024年连续第六年在上市数量上击败纽约证券交易所。根据 Dealogic 和纳斯达克提供的数据，今年前 11 个月，在纳斯达克进行首次公开募股的公司达 160 家，募集资金约 220 亿美元，超过了纽约证券交易所 34 次上市募集的近 170 亿美元。这是 三年来最高的上市 量。近年来，在美联储于 2022 年提高利率以遏制飙升的通胀之后，首次公开募股交易量出现 下滑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4S3NH0PB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["82020","LU1059921491.USD","LU1868836757.USD","IE00B3QW5Z07.USD","LU1032955483.USD","NVDY","3NVD.UK","LU0048597586.USD","02020","NVD2.UK","NVIW.SI","IE00BN29S564.USD","ICE","MSFT","LINE","ANPDY","NVDU","BK1227","BK4525","IE00B775H168.HKD","NVDS.UK","IE0009G5SDU7.USD","SGXZ81514606.USD","SNVD.UK","LU2237443549.SGD","NVDX","VIK","NVD","NVDA","LU0724617625.USD","LU1340139317.AUD","LU2360108059.USD","LU2125154935.USD","NVDD","LU2065171402.SGD","PLTR","AS","LU1435385759.SGD","LU2095319765.USD","NVDS","LU0095938881.EUR","LU2413666699.HKD","LU0154245673.USD","LU0979878070.USD","RBRK","2NVD.UK","NVD3.UK","NDAQ"],"gpt_icon":1},{"id":"2491544336","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491544336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491544336?lang=zh_cn&edition=full","pubTime":"2024-12-13 00:24","pubTimestamp":1734020694,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日00时24分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速下跌5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.98%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002454a1e98583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213002454a1e98583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2489740234","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489740234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489740234?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:24","pubTimestamp":1733498651,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时24分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.71%。其相关个股中，Adc Therapeutics Sa、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Cervomed Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为52.41%、40.07%、27.52%，振幅较大的相关个股有Adc Therapeutics Sa、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为33.33%、27.68%、26.58%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232411a1d98b83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206232411a1d98b83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","LENZ","BK4224","LCTX"],"gpt_icon":0},{"id":"2489450366","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速上涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489450366","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489450366?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:34","pubTimestamp":1733409299,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时34分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.02%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1818.92%、252.17%、207.62%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Alx Oncology Holdings Inc.，振幅分别为38.70%、22.62%、12.74%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223459971be18c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223459971be18c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","LINE","BK4224","BK4139"],"gpt_icon":0},{"id":"2488244219","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.05%报0.559美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488244219","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488244219?lang=zh_cn&edition=full","pubTime":"2024-12-04 02:43","pubTimestamp":1733251417,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日02时43分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅跳水5.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Janux Therapeutics, Inc.、Jupiter Neurosciences Inc涨幅较大，Quoin Pharmaceuticals Ltd、Nls Pharmaceutics Ltd.、Purple Biotech Ltd较为活跃，换手率分别为168.77%、148.10%、145.27%，振幅较大的相关个股有Jupiter Neurosciences Inc、Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为134.75%、69.23%、59.76%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120402433798e52653&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120402433798e52653&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","BK4139","LENZ","BK4224","LCTX"],"gpt_icon":0},{"id":"2488605871","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘股价大涨5.95%报0.606美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488605871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488605871?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:21","pubTimestamp":1733156491,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时21分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅上涨5.95%。截至发稿，该股报0.606美元/股，成交量85.323万股，换手率0.39%，振幅4.90%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203002131a266d044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203002131a266d044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4224","LINE","LENZ","LCTX"],"gpt_icon":0},{"id":"2486808549","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.32%报0.573美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486808549","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486808549?lang=zh_cn&edition=full","pubTime":"2024-11-28 01:45","pubTimestamp":1732729521,"startTime":"0","endTime":"0","summary":"北京时间2024年11月28日01时45分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫5.32%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.81%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128014522971a8f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128014522971a8f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LINE","LENZ","BK4139","BK4224","LCTX"],"gpt_icon":0},{"id":"2486001599","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘快速拉升5.00%报0.603美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486001599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486001599?lang=zh_cn&edition=full","pubTime":"2024-11-26 22:35","pubTimestamp":1732631751,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日22时35分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速上涨5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.11%。其相关个股中，Poseida Therapeutics, Inc.、Fate Therapeutics, Inc.、Cabaletta Bio, Inc.涨幅较大，Oncternal Therapeutics, Inc.、Poseida Therapeutics, Inc.、木薯科学较为活跃，换手率分别为13.88%、10.79%、9.44%，振幅较大的相关个股有Cabaletta Bio, Inc.、Fate Therapeutics, Inc.、Caribou Biosciences, Inc.，振幅分别为18.77%、16.32%、15.35%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223551abe0bea0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126223551abe0bea0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LCTX","BK4224","BK4139","LINE"],"gpt_icon":0},{"id":"2486038314","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大涨6.01%报0.534美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038314","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038314?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545198,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升6.01%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.70%、60.78%、38.33%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522331898e44650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522331898e44650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LINE","BK4139","LCTX","BK4224"],"gpt_icon":0},{"id":"2485916032","title":"Lineage Cell Therapeutics, Inc.盘中异动 股价大跌5.00%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485916032","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485916032?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:27","pubTimestamp":1732296454,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时27分，Lineage Cell Therapeutics, Inc.股票出现波动，股价大幅下挫5.00%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.78%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Replimune Group, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1842.13%、149.84%、93.34%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为72.75%、71.43%、63.64%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301273498e44354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112301273498e44354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2485298756","title":"Lineage Cell Therapeutics, Inc.2024财年第三财季实现净利润-3.03百万美元，同比增加57.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298756?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:03","pubTimestamp":1732291393,"startTime":"0","endTime":"0","summary":"11月23日，Lineage Cell Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-3.03百万美元，同比增加57.38%；其中营业收入为3.78百万美元，同比增加202.40%，每股基本收益为-0.02美元。从资产负债表来看，Lineage Cell Therapeutics, Inc.总负债31.80百万美元，其中短期债务1.14百万美元，资产负债比为3.04，流动比率为2.49。机构评级：截至2024年11月23日，当前有6家机构对Lineage Cell Therapeutics, Inc.目标价做出预测，其中目标均价为4.17美元，其中最低目标价为2.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000337a24e49af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000337a24e49af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LENZ","LINE"],"gpt_icon":0},{"id":"2485497420","title":"Lineage Cell Therapeutics, Inc.盘中异动 快速跳水5.66%报0.605美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485497420?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:39","pubTimestamp":1732199958,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时39分，Lineage Cell Therapeutics, Inc.股票出现异动，股价大幅下挫5.66%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112122391898e43edd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","LINE","BK4224","BK4139","LENZ"],"gpt_icon":0},{"id":"2484110850","title":"Lineage Cell Therapeutics, Inc.股价重挫19.73% 市值跌2701.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484110850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484110850?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:31","pubTimestamp":1732113078,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时31分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速下挫19.73%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Forte Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为439.66%、130.77%、88.84%，振幅较大的相关个股有Silexion Therapeutics Corp、Tonix Pharmaceuticals Holding Corp.、Forte Biosciences, Inc.，振幅分别为17.77%、17.64%、17.55%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112022311895be4c8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LCTX","BK4139","LENZ","BK4224","LINE"],"gpt_icon":0},{"id":"2484764466","title":"Lineage Cell Therapeutics, Inc.盘中异动 急速上涨5.41%报0.911美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484764466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484764466?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:36","pubTimestamp":1731940563,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时36分，Lineage Cell Therapeutics, Inc.股票出现异动，股价急速拉升5.41%。截至发稿，该股报0.911美元/股，成交量3.6726万股，换手率0.02%，振幅2.05%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822360395be48b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4224","LINE","LCTX"],"gpt_icon":0},{"id":"2483377366","title":"Lineage Cell Therapeutics, Inc.盘中异动 早盘大幅拉升5.08%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377366?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:30","pubTimestamp":1731681013,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时30分，Lineage Cell Therapeutics, Inc.股票出现波动，股价急速上涨5.08%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Lyra Therapeutics, Inc.、Cybin Inc.、Senti Biosciences, Inc.涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2672.48%、153.67%、44.16%，振幅较大的相关个股有Abvc Biopharma, Inc.、Gain Therapeutics, Inc.、Bioatla, Inc.，振幅分别为4.17%、4.01%、2.34%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522301498e42ea2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE","LCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2483234848","title":"英国对华钢丝绳和钢缆作出反倾销过渡性审查终裁","url":"https://stock-news.laohu8.com/highlight/detail?id=2483234848","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483234848?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:10","pubTimestamp":1731658230,"startTime":"0","endTime":"0","summary":"同时裁定转口自摩洛哥及韩国的钢丝绳和钢缆适用的税率同上。该措施自2023年4月21起生效，为期五年。涉案产品的英国海关编码为7312108112、7312108113、7312108119、7312108312、7312108313、7312108319、7312108512、7312108513、7312108519、7312108912、7312108913、7312108919、7312109812、7312109813、7312109819。倾销调查期为2022年1月1日至2022年12月31日，损害调查期为2019年1月1日至2022年12月31日。2023年3月30日，英国贸易救济署发布公告，对原产于中国的钢丝绳和钢缆反倾销措施立案进行过渡性审查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161030a23a50dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161030a23a50dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4224","LINE"],"gpt_icon":0},{"id":"2483983992","title":"Lineage Cell Therapeutics, Inc.盘中异动 临近午盘大幅跳水6.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483983992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483983992?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:39","pubTimestamp":1731515977,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时39分，Lineage Cell Therapeutics, Inc.股票出现波动，股价快速下挫6.89%。Lineage Cell Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Syros Pharmaceuticals, Inc.较为活跃，换手率分别为484.15%、288.62%、105.25%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Calidi Biotherapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为88.00%、67.77%、52.89%。Lineage Cell Therapeutics, Inc.公司简介：Lineage Cell Therapeutics Inc是一家临床阶段的生物技术公司，专注于开发和商业化用于治疗退行性疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114003937971a6574&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LINE","LCTX","BK4224","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.onelineage.com","stockEarnings":[{"period":"1week","weight":-0.0556},{"period":"1month","weight":-0.0828},{"period":"3month","weight":-0.2765},{"period":"6month","weight":-0.2491},{"period":"ytd","weight":-0.2491}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Lineage, Inc.于2017年在马里兰州成立，是世界上最大的全球温度控制仓库房地产投资信托基金，拥有现代化和战略性的房地产网络。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.009942},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.051794},{"month":3,"riseRate":0.181818,"avgChangeRate":-0.047075},{"month":4,"riseRate":0.909091,"avgChangeRate":0.072457},{"month":5,"riseRate":0.272727,"avgChangeRate":-0.085175},{"month":6,"riseRate":0.7,"avgChangeRate":0.017118},{"month":7,"riseRate":0.6,"avgChangeRate":-0.034691},{"month":8,"riseRate":0.2,"avgChangeRate":-0.040778},{"month":9,"riseRate":0.4,"avgChangeRate":-0.041279},{"month":10,"riseRate":0.7,"avgChangeRate":0.025106},{"month":11,"riseRate":0.4,"avgChangeRate":-0.07115},{"month":12,"riseRate":0.6,"avgChangeRate":-0.044918}],"exchange":"NASDAQ","name":"Lineage","nameEN":"Lineage"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Lineage,LINE,Lineage股票,Lineage股票老虎,Lineage股票老虎国际,Lineage行情,Lineage股票行情,Lineage股价,Lineage股市,Lineage股票价格,Lineage股票交易,Lineage股票购买,Lineage股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lineage(LINE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Lineage(LINE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}